Re-vaccination For Hepatitis B in Previous Non-Responders Following Hepatitis C Eradication.

Hepatitis B virus vaccine direct-acting antiviral hepatitis B virus vaccine nonresponse hepatitis C virus

Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
31 Jul 2023
Historique:
received: 26 04 2023
revised: 11 07 2023
accepted: 28 07 2023
medline: 31 7 2023
pubmed: 31 7 2023
entrez: 31 7 2023
Statut: aheadofprint

Résumé

Patients with chronic HCV do not respond to HBV vaccination as efficiently as the general population. We assessed if re-vaccination after HCV treatment resulted in improved response. Previous HBV vaccine non-responders were prospectively recruited for revaccination after HCV eradication. HBsAb testing was performed one month after series completion. Follow-up HBsAb testing was performed in 31 out of 34 enrolled patients with 21 (67.7%) reactive results. There were no significant differences in HBsAb reactivity based on age, sex, race, or advanced fibrosis presence. HBV vaccine non-responders should be considered for re-vaccination following HCV cure.

Identifiants

pubmed: 37523757
pii: 7234307
doi: 10.1093/infdis/jiad301
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Auteurs

Jesse G Powell (JG)

Department of Gastroenterology and Hepatology, Hennepin Healthcare, Minneapolis, MN, USA.

Spencer R Goble (SR)

Department of Medicine, Hennepin Healthcare, Minneapolis, MN, USA.

Jose D Debes (JD)

Department of Gastroenterology and Hepatology, Hennepin Healthcare, Minneapolis, MN, USA.
Department of Medicine, University of Minnesota, Minneapolis, MN, USA.

Classifications MeSH